Hepatitis Monthly

Published by: Kowsar

Prevalence and Risk Factors of Hepatitis B and C Virus Infections Among Patients Undergoing Hemodialysis in Kurdistan, Iraq

Hussein Yousif Abdullah Sinjari 1 , * and Krdar Abdulkhaleq Bakr 2
Authors Information
1 Department of Internal Medicine, Hawler Medical University, Erbil, Iraq
2 Kurdistan Board of Medical Specialties, Erbil, Iraq
Article information
  • Hepatitis Monthly: May 2018, 18 (5); e11776
  • Published Online: May 14, 2018
  • Article Type: Research Article
  • Received: April 15, 2017
  • Revised: December 26, 2017
  • Accepted: January 30, 2018
  • DOI: 10.5812/hepatmon.11776

To Cite: Abdullah Sinjari H Y, Bakr K A. Prevalence and Risk Factors of Hepatitis B and C Virus Infections Among Patients Undergoing Hemodialysis in Kurdistan, Iraq, Hepat Mon. 2018 ; 18(5):e11776. doi: 10.5812/hepatmon.11776.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization . Hepatitis B fact sheet updated July 2016. 2016. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
  • 2. World Health Organization . Hepatitis C fact sheet updated July 2016. 2016. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.
  • 3. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. [PubMed: 22436845].
  • 4. European Association for Study of L. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014;60(2):392-420. doi: 10.1016/j.jhep.2013.11.003. [PubMed: 24331294].
  • 5. Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transplant. 2011;4(1):35-47. doi: 10.4314/ajnt.v4i1.63154. [PubMed: 21469594].
  • 6. Bernieh B. Viral hepatitis in hemodialysis: An update. J Transl Int Med. 2015;3(3):93-105. doi: 10.1515/jtim-2015-0018. [PubMed: 27847896]. [PubMed Central: PMC4936461].
  • 7. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63(6):2222-9. doi: 10.1046/j.1523-1755.2003.00017.x. [PubMed: 12753311].
  • 8. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65(6):2335-42. doi: 10.1111/j.1523-1755.2004.00649.x. [PubMed: 15149347].
  • 9. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2009;24(5):1598-603. doi: 10.1093/ndt/gfn684. [PubMed: 19096083].
  • 10. SCOT . Saudi center for organ transplantation- annual report 2015, page 83. 2015. Available from: www.scot.org.sa/pages/Doc15.
  • 11. Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World J Gastroenterol. 2017;23(1):151-66. doi: 10.3748/wjg.v23.i1.151. [PubMed: 28104991]. [PubMed Central: PMC5221279].
  • 12. Tarky AA, Akram W, Al-Naaimi A, Omer A. Epidemiology of viral hepatitis B and C in Iraq: a national survey 2005-2006. Zanco J Med Sci. 2013;17(1):370-80. doi: 10.15218/zjms.2013.0017.
  • 13. Shihab S, Al-Hmudi H, Aledani H, Mahdi K. Viral hepatitis infections in Basrah haemodialysis unit:Serological diagnosis and viral loading. Euro J of Experimental Bio. 2014;4(2):106-12.
  • 14. Al Hijazat M, Ajlouni YM. Hepatitis B infection among patients receiving chronic hemodialysis at the Royal Medical Services in Jordan. Saudi J Kidney Dis Transpl. 2008;19(2):260-7. [PubMed: 18310881].
  • 15. Al Zabadi H, Rahal H, Fuqaha R. Hepatitis B and C prevalence among hemodialysis patients in the West Bank hospitals, Palestine. BMC Infect Dis. 2016;16:41. doi: 10.1186/s12879-016-1359-8. [PubMed: 26830673]. [PubMed Central: PMC4736137].
  • 16. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012;12(5):339-43. doi: 10.5812/hepatmon.5969. [PubMed: 22783346]. [PubMed Central: PMC3389360].
  • 17. Suleymanlar G, Altiparmak MR, Seyahi N. National hemodialysis, transplant and nephrology registry report of Turkey, 2011. Istanbul: Turkish Nephrology society: Pasific Press; 2012.
  • 18. Yuan J, Yang Y, Han F, Zhang P, Du XY, Jiang H, et al. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus. Hepatobiliary Pancreat Dis Int. 2012;11(3):302-6. doi: 10.1016/S1499-3872(12)60164-7. [PubMed: 22672825].
  • 19. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis. 2012;12:265. doi: 10.1186/1471-2334-12-265. [PubMed: 23082935]. [PubMed Central: PMC3507892].
  • 20. Su Y, Yan R, Duan Z, Norris JL, Wang L, Jiang Y, et al. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China. J Med Virol. 2013;85(3):425-32. doi: 10.1002/jmv.23486. [PubMed: 23341370].
  • 21. Sarhan II, Kamel CR. Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt. Egypt Liver J. 2015;5(2):34-9. doi: 10.1097/01.elx.0000463167.48017.41.
  • 22. Girou E, Chevaliez S, Challine D, Thiessart M, Morice Y, Lesprit P, et al. Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis. 2008;47(5):627-33. doi: 10.1086/590564. [PubMed: 18662134].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments